ProShare Advisors LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$285,188
-35.1%
6,872
-6.0%
0.00%0.0%
Q1 2023$439,684
-40.3%
7,311
-27.2%
0.00%
-66.7%
Q4 2022$737,094
-5.3%
10,049
-1.9%
0.00%0.0%
Q3 2022$778,000
+16.5%
10,244
+6.5%
0.00%
+50.0%
Q2 2022$668,000
-37.2%
9,619
-25.1%
0.00%0.0%
Q1 2022$1,064,000
-16.0%
12,846
-23.8%
0.00%0.0%
Q4 2021$1,266,000
+416.7%
16,863
+700.0%
0.00%
+100.0%
Q3 2021$245,000
-64.4%
2,108
-32.1%
0.00%
-50.0%
Q2 2021$688,000
+226.1%
3,103
+94.3%
0.00%
+100.0%
Q1 2021$211,000
-19.8%
1,597
+5.2%
0.00%0.0%
Q4 2020$263,000
-86.7%
1,518
-91.4%
0.00%
-88.9%
Q3 2020$1,974,000
+107.4%
17,733
+10.5%
0.01%
+80.0%
Q2 2020$952,000
-24.4%
16,050
-14.2%
0.01%
-44.4%
Q1 2020$1,260,000
-54.9%
18,704
-43.6%
0.01%
-30.8%
Q4 2019$2,796,000
+2.5%
33,179
-9.0%
0.01%
-13.3%
Q3 2019$2,727,000
+20.7%
36,472
+2.0%
0.02%
+7.1%
Q2 2019$2,260,000
+16.5%
35,744
-11.2%
0.01%
+16.7%
Q1 2019$1,940,000
+47.5%
40,271
+2.5%
0.01%
+33.3%
Q4 2018$1,315,000
-46.5%
39,290
-16.2%
0.01%
-47.1%
Q3 2018$2,457,000
+65.0%
46,887
-1.5%
0.02%
+70.0%
Q2 2018$1,489,000
+39.3%
47,582
-3.0%
0.01%
+42.9%
Q1 2018$1,069,000
-6.7%
49,042
-13.5%
0.01%
-12.5%
Q4 2017$1,146,000
+6.7%
56,718
+4.8%
0.01%
-20.0%
Q3 2017$1,074,000
+23.3%
54,098
+7.4%
0.01%
+11.1%
Q2 2017$871,000
+105.4%
50,351
-3.7%
0.01%
+125.0%
Q1 2017$424,000
-17.5%
52,305
-20.1%
0.00%
-33.3%
Q4 2016$514,00065,4670.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders